Accueil › Cancer colorectal › Arizona › Scottsdale
Essais cliniques pour Cancer colorectal à Scottsdale, AZ
16 études pour Cancer colorectal recherchent des participants dans et autour de Scottsdale (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Recrutement en coursPhase 1
- Honor Health Research Institute, Scottsdale
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Recrutement en coursPhase 3
- Mayo Clinic, Scottsdale
- Ironwood Cancer & Research Centers, Scottsdale
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Recrutement en coursPhase 1/2
- HonorHealth Research Institute, Scottsdale
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Recrutement en coursPhase 1
- HonorHealth, Scottsdale
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
Recrutement en coursPhase 1/2
- HonorHealth Research Institute, Scottsdale
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Recrutement en coursPhase 2
- Research Site, Scottsdale
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Recrutement en coursÉtude observationnelle
- Mayo Clinic in Arizona, Scottsdale
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- Honor Health, Scottsdale
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Recrutement en coursPhase 1/2
- Mayo Clinic (Arizona), Scottsdale
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Recrutement en coursPhase 3
- Mayo Clinic, Scottsdale
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Recrutement en coursPhase 1
- Mayo Clinic, Scottsdale
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Recrutement en coursVolontaires sains bienvenus
- Mayo Clinic in Arizona, Scottsdale
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
Recrutement en coursPhase 1/2
- Clinical Trials Nurse Navigator, Scottsdale
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Recrutement en coursPhase 4
- Scottsdale Medical Imaging, LLC, Scottsdale
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Recrutement en coursPhase 1/2
- Mayo Clinic in Arizona, Scottsdale
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Recrutement en coursPhase 1
- HonorHealth Research Institute, Scottsdale
Essais pour Cancer colorectal dans d'autres villes
- Houston, TX102 études
- New York City, NY78 études
- Nashville, TN69 études
- Boston, MA63 études
- Los Angeles, CA59 études
- Arlington, VA52 études
- St. Louis, MO50 études
- San Antonio, TX46 études
- Philadelphia, PA44 études
- Grand Rapids, MI40 études
- Baldwin Park, CA37 études
- Chicago, IL34 études
Autres études à Scottsdale
- Cancer du sein18 études
- Cancer (tous types)18 études
- Cancer métastatique17 études
- Cancer de la prostate17 études
- Cancer du poumon non à petites cellules15 études
- Cancer du pancréas13 études
- Mélanome10 études
- Colite ulcéreuse8 études
- Cancer du poumon8 études
- Cancer du foie (carcinome hépatocellulaire)7 études
- Maladie d'Alzheimer7 études
- Cancer du sein triple négatif7 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.